Related Experiment Video

Updated: Aug 8, 2026

DNA Vector-based RNA Interference to Study Gene Function in Cancer
13:10

DNA Vector-based RNA Interference to Study Gene Function in Cancer

Published on: June 4, 2012

Targeting and eradicating cancer cells by a prostate-specific vector carrying the diphtheria toxin A gene

S Pang1

  • 1Division of Oral Biology and Medicine, University of California Los Angeles School of Dentistry, 90095-1668, USA. shenp@dent.ucla.edu

Cancer Gene Therapy
|August 5, 2000
PubMed

Insights

Researchers developed a targeted gene therapy for prostate cancer using a specific promoter to deliver the diphtheria toxin A (DTA) gene. This approach shows promise for treating advanced prostate cancer by selectively killing cancer cells.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy

Background:

  • Prostate cancer is a leading malignancy in men, with limited treatment options for advanced stages.
  • Tissue-specific promoters offer a targeted approach for gene therapy, enhancing efficacy and reducing side effects.
  • The prostate-specific antigen (PSA) gene promoter is a key target for developing prostate-specific gene expression.

Purpose of the Study:

  • To engineer a prostate-specific promoter for targeted gene therapy of prostate cancer.
  • To evaluate the efficacy of delivering the diphtheria toxin A (DTA) gene to prostate cancer cells using the modified promoter.

Main Methods:

  • Constructed a modified prostate-specific promoter based on the PSA gene regulatory elements.
  • Cloned the diphtheria toxin A (DTA) gene into a plasmid vector driven by the engineered promoter.
  • Utilized liposome-mediated transfection to introduce the DTA gene vector into LNCaP prostate cancer cells and control cell lines.

Main Results:

  • The DTA gene was effectively transcribed in the transfected LNCaP prostate cancer cells.
  • Significant inhibition of protein synthesis and observable cytopathic effects were noted in cancer cells.
  • No adverse effects were observed in control cell lines, indicating high specificity.

Conclusions:

  • The engineered prostate-specific DTA gene vector demonstrates high specificity and potent cytopathicity against prostate cancer cells.
  • This targeted gene therapy approach holds potential for the systemic treatment of metastatic prostate cancer.

More Related Videos

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration06:21

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration

Published on: April 27, 2018

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

Related Concept Videos

In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...